Triverity Laboratories Webinar Series: Impurities in Drug Substance and Drug Product скачать в хорошем качестве

Triverity Laboratories Webinar Series: Impurities in Drug Substance and Drug Product

Join Wendi Young, CEO of Triverity Laboratories, as she presents a practical and scientific overview of impurities in pharmaceutical products. This webinar explores how impurity identification, structural characterization, and lifecycle‑appropriate control strategies support product quality and regulatory compliance throughout development. This session covers: • Types of impurities and why they matter • Approaches for impurity identification and structural characterization • How impurity profiles evolve across the product lifecycle • Control strategies aligned with ICH Q3A and Q3B • Practical considerations for development, quality and regulatory teams This webinar also includes a live Q&A, offering insight into real‑world impurity challenges encountered by development, QA and regulatory professionals. Subscribe to our channel for more webinars and insights: @TriverityLaboratories Recorded live on Wednesday 4th March 2026 at 9am MT (UTC‑7)